Literature DB >> 35943700

Synthesis of silver nanoparticles using Alpinia officinarum rhizome extract induces apoptosis through down-regulating Bcl-2 in human cancer cells.

Harika Atmaca1, Çisil Çamlı Pulat2, Suleyman Ilhan3.   

Abstract

In this study, silver nanoparticles were synthesized using Alpinia officinarum rhizome extract via an eco-friendly green synthesis method. The silver nanoparticles (AO-AgNPs) were characterized by UV-Vis spectrometry, scanning electron microscopy, energy-dispersive X-ray spectroscopy, and dynamic light scattering. Further, the cytotoxic and apoptotic effects of AO-AgNPs were investigated in human cancer cells with different tissue origins via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and flow cytometric analyses, respectively. The expression levels of anti-apoptotic Bcl-2 protein were evaluated via a real-time polymerase chain reaction. The synthesized AO-AgNPs induced a significant cytotoxic effect in all tested cancer cells but not in normal cells. AO-AgNPs induced the percentage of apoptotic cells and reduced the levels of anti-apoptotic Bcl-2 mRNA levels in cancer cells. These results demonstrate the potential application of AO-AgNPs in cancer treatment.
© 2022. Akadémiai Kiadó Zrt.

Entities:  

Keywords:  Alpinia officinarum; Anticancer; Apoptosis; Bcl-2; Silver nanoparticles

Mesh:

Substances:

Year:  2022        PMID: 35943700     DOI: 10.1007/s42977-022-00132-5

Source DB:  PubMed          Journal:  Biol Futur        ISSN: 2676-8607


  15 in total

Review 1.  Cell death: critical control points.

Authors:  Nika N Danial; Stanley J Korsmeyer
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

3.  Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells.

Authors:  Harika Atmaca; Selim Uzunoglu
Journal:  Eur Cytokine Netw       Date:  2014-03-01       Impact factor: 2.737

Review 4.  Role of gold and silver nanoparticles in cancer nano-medicine.

Authors:  Heerak Chugh; Damini Sood; Ishita Chandra; Vartika Tomar; Gagan Dhawan; Ramesh Chandra
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-03-13       Impact factor: 5.678

Review 5.  Exploring silver nanoparticles for cancer therapy and diagnosis.

Authors:  Renata Rank Miranda; Isabella Sampaio; Valtencir Zucolotto
Journal:  Colloids Surf B Biointerfaces       Date:  2021-11-29       Impact factor: 5.268

6.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells.

Authors:  P V AshaRani; Grace Low Kah Mun; Manoor Prakash Hande; Suresh Valiyaveettil
Journal:  ACS Nano       Date:  2009-02-24       Impact factor: 15.881

7.  Synthesis, characterization, biocompatible and anticancer activity of green and chemically synthesized silver nanoparticles - A comparative study.

Authors:  Sivaiah Kummara; Mrityunjaya B Patil; Tiewlasubon Uriah
Journal:  Biomed Pharmacother       Date:  2016-09-14       Impact factor: 6.529

8.  Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund's adjuvant-induced arthritis in rats.

Authors:  JiSuk Lee; Kyoung Ah Kim; SeonHui Jeong; SungGeum Lee; Hi Joon Park; Nam Jae Kim; Sabina Lim
Journal:  J Ethnopharmacol       Date:  2009-08-26       Impact factor: 4.360

Review 9.  A Review on the Pharmacological Activities and Phytochemicals of Alpinia officinarum (Galangal) Extracts Derived from Bioassay-Guided Fractionation and Isolation.

Authors:  Aida Maryam Basri; Hussein Taha; Norhayati Ahmad
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

10.  Antiproliferative activity and induction of apoptotic by ethanolic extract of Alpinia galanga rhizhome in human breast carcinoma cell line.

Authors:  Saeed Samarghandian; Mousa-Al-Reza Hadjzadeh; Jalil Tavakkol Afshari; Mohadeseh Hosseini
Journal:  BMC Complement Altern Med       Date:  2014-06-17       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.